Reported Earlier, Q32 Bio Announces $200M Offering, Including 6,027,399 Common Shares At $18.25 Each And Pre-Funded Warrants For 4,931,506 Shares At $18.2499

Benzinga Newsdesk www.benzinga.com Neutral 91.4%

Neg 0% Neu 91.4% Pos 0%

Comments

No comments yet. Be the first!